Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Matrix metalloproteinase 15 (MMP15), also known as membrane-type 2 matrix metalloproteinase (MT2-MMP), is a membrane-bound zinc-dependent endopeptidase that plays a critical role in extracellular matrix (ECM) remodeling (UniProt: P51511). Unlike soluble MMPs, MMP15 is anchored to the cell membrane via a hydrophobic transmembrane domain, allowing localized proteolytic activity at the cell-matrix interface. It degrades key ECM components such as fibronectin, tenascin, and laminin, and acts as an activator of other metalloproteinases like pro-MMP2.
In pathological contexts, MMP15 is frequently upregulated in various malignancies, including lung, colon, and ovarian cancers, where it facilitates tumor cell invasion, metastasis, and tumor-induced angiogenesis. Historically, therapeutic targeting of MMPs relied on broad-spectrum small-molecule inhibitors like Marimastat and Batimastat; however, these failed in clinical trials due to severe dose-limiting musculoskeletal toxicity and lack of selectivity. Current drug discovery efforts focus on developing highly selective monoclonal antibodies or small molecules that target the unique allosteric sites or the hemopexin domain of MMP15 to minimize off-target effects.
Inhibition of enzymatic activity by chelating the active-site zinc ion or blocking the substrate-binding pocket.
3 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matrix metalloproteinase 15 (MMP15).